Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin

N. Eckstein, I. Vagman, A. Eshel, Z. Naor, D. Ayalon

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

In five hypothalamic amenorrhea patients who underwent chronic intermittent gonadotropin-releasing hormone (GnRH) therapy for induction of ovulation, small doses (2 to 4 ampules/day) of human menopausal gonadotropin (hMG) were administered 9 to 32 days after the start of GnRH treatment. In seven treatment cycles, the addition of hMG initiated a sudden rise of 17β-estradiol concentrations, followed by a luteinizing hormone and follicle-stimulating hormone surge and ultrasonographic evidences of ovulation. Four of five patients conceived (singleton pregnancies) after the first or second treatment course. There were no clinical signs of ovarian hyperstimulation. Combined therapy of GnRH and hMG may be useful, therefore, for the treatment of hypothalamic amenorrhea patients who demonstrate prolonged follicular phases or luteinized unruptured follicle syndrome under chronic treatment with pulsatile GnRH alone.

Original languageEnglish
Pages (from-to)744-750
Number of pages7
JournalFertility and Sterility
Volume44
Issue number6
DOIs
StatePublished - 1985

Fingerprint

Dive into the research topics of 'Induction of ovulation in amenorrheic patients with gonadotropin-releasing hormone and human menopausal gonadotropin'. Together they form a unique fingerprint.

Cite this